The HMG20A Knockout A-549 Polyclonal Cells represent a polyclonal population of A-549 lung adenocarcinoma epithelial cells engineered via CRISPR/Cas9-mediated disruption of the HMG20A gene. This knockout model enables loss-of-function studies of the chromatin-associated transcriptional repressor HMG20A within an established epithelial context.
The A-549 cell line is a widely utilized model of alveolar Type II epithelial cells, derived from a 58-year-old Caucasian male lung adenocarcinoma patient. These adherent cells exhibit an epithelial morphology and harbor a KRAS G12S mutation while retaining wild-type p53, rendering them a genetically defined platform for investigating oncogenic signaling and respiratory disease mechanisms.
HMG20A encodes a chromatin-associated protein that functions as a transcriptional repressor within the BRAF35-HDAC complex, which includes BRAF35 (HMG20B), HDAC1, HDAC2, BHC80 (PHF21A), REST, and CoREST. This complex mediates REST-dependent silencing of neuronal genes such as SYN1, SYP, and GRIN1 in non-neuronal cells. HMG20A activity is regulated by upstream factors including REST/NRSF, ??-catenin/TCF, Notch intracellular domain, and SOX2, linking it to Wnt, Notch, and REST/NRSF signaling pathways. Knockout of HMG20A disrupts this repressive complex, potentially leading to derepression of neuron-specific genes and altered chromatin remodeling.
In the A-549 background, HMG20A knockout provides a relevant model for studying the role of REST-mediated repression in lung adenocarcinoma epithelial cells. Given the association of HMG20A with neurodevelopmental disorders and its function in neuronal differentiation, this model is particularly suited for investigating epigenetic mechanisms underlying neuroendocrine differentiation in lung cancer and exploring the interplay between the REST complex and oncogenic signaling pathways such as Wnt and Notch.
Researchers can employ these polyclonal knockout cells in a range of assays to dissect HMG20A function. For example, ChIP-qPCR and RNA-seq can be used to assess genome-wide changes in histone modifications and transcriptional programs upon HMG20A loss. Functional studies may include proliferation, migration, and invasion assays to evaluate effects on tumor cell behavior, along with drug sensitivity screens to identify context-specific vulnerabilities. Immunofluorescence and flow cytometry enable analysis of neuronal marker expression, while western blotting and RT-qPCR confirm target gene regulation. For further information, please contact Ascent Research.
